Overview

If you are looking to advance your career in Math & Natural Sciences, the Master's Programme in Molecular and Translational Neuroscience at Ulm University is an excellent choice. This Master degree focuses on equipping students with the necessary skills to excel in a global environment. The courses are taught in English, allowing for a diverse international atmosphere. You can expect to complete your studies in 4 semesters. The estimated cost for this program is €1,500. Molecular and Translational Neuroscience (MTN) is a research-oriented Master's programme designed to provide students with advanced training in both basic research as well as clinically and therapeutically oriented neuroscience. One of the objectives of Molecular and Translational Neuroscience is to improve the diagnosis and treatment of neurological and psychiatric disorders such as multiple sclerosis, stroke, depression, schizophrenia, traumatic brain injury (TBI), Amyotrophic Lateral Sclerosis (ALS), and age-related diseases such as dementia and Parkinson's disease. These conditions can significantly impact patients' quality of life and, in severe cases, may lead to complete loss of independence. Current therapies often lack sufficient efficacy due to limited understanding of the underlying pathomechanisms. Therefore, Molecular and Translational Neuroscience focuses on the investigation of physiological and pathophysiological mechanisms involved in the adaptation and homeostasis of the nervous system and serves as a bridge, linking basic cellular and pharmacological studies, molecular neurobiology, behavioural physiology, and diagnostics as well as pharmacological applications. The knowledge gained can then be translated into targeted approaches for innovative therapies and preventive strategies. Our English-taught MTN programme provides specific theoretical, methodological and practical knowledge of cellular and molecular processes in neural cells and in the nervous system that lead to disease as well as the application of this knowledge to potential new diagnostic and therapeutic procedures and clinical applications. Furthermore, the close interaction with our industrial partner Boehringer Ingelheim provides insights into the work of a pharmaceutical company. If certain data points are not listed, we recommend you refer to the institution for exact details.

Back to programs